Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach

被引:2
作者
Bu, Rong [1 ]
Siraj, Abdul K. [1 ]
Parvathareddy, Sandeep Kumar [1 ]
Iqbal, Kaleem [1 ]
Azam, Saud [1 ]
Qadri, Zeeshan [1 ]
Al-Rasheed, Maha [1 ]
Haqawi, Wael [1 ]
Diaz, Mark [1 ]
Alobaisi, Khadija [1 ]
Annaiyappanaidu, Padmanaban [1 ]
Siraj, Nabil [1 ]
AlHusaini, Hamed [2 ]
Alomar, Osama [3 ]
Al-Badawi, Ismail A. [3 ]
Al-Dayel, Fouad [4 ]
Al-Kuraya, Khawla S. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Human Canc Genom Res, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Med Oncol, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Obstet Gynecol, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
关键词
endometrial cancer; Lynch syndrome; mismatch repair-deficient; Lynch-like syndrome; universal screening; germline mutations; somatic mutations; PAPILLARY THYROID-CANCER; MUTATIONS; VARIANTS; PATTERNS; COMMON;
D O I
10.3390/ijms232012299
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lynch syndrome (LS) is the most common cause of inherited endometrial cancer (EC). The prevalence and molecular characteristic of LS in Middle Eastern women with EC have been underexplored. To evaluate the frequency of LS in a cohort of EC patients from Saudi Arabia, a total of 436 EC cases were screened utilizing immunohistochemistry (IHC), MLH1 promoter methylation analysis and next-generation sequencing technology. A total of 53 of 436 (12.2%) ECs were classified as DNA mismatch repair-deficient (dMMR). MLH1 promoter hypermethylation was detected in 30 ECs (6.9%). Three ECs (0.7%) were found to be LS harboring germline pathogenic variants (PVs)/likely pathogenic variants (LPVs): two in the MSH2 gene and one in the MSH6 gene. Three ECs (0.7%) were Lynch-like syndrome (LLS) carrying double somatic MSH2 PVs/LPVs. Seven cases were found to have variants of uncertain significance in cancer-related genes other than MMR genes. Our results indicate that LS prevalence is low among Saudi EC patients and LLS is as common as LS in this ethnicity. Our findings could help in better understanding of the prevalence and mutational spectrum of this syndrome in Saudi Arabia, which may help in defining best strategies for LS identification, prevention and genetic counseling for EC patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach
    Alves Rosa, Reginaldo Cruz
    Santis, Jessica Oliveira
    Teixeira, Lorena Alves
    Molfetta, Greice Andreotti
    Targino dos Santos, Jennifer Thalita
    Ribeiro, Vanessa dos Santos
    Chahud, Fernando
    Ribeiro-Silva, Alfredo
    Brunaldi, Mariangela Ottoboni
    Silva Jr, Wilson Araujo
    de Faria Ferraz, Victor Evangelista
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 229 - 238
  • [2] Lynch Syndrome Identification in Endometrial Cancer Patients: Should Universal Screening be Used for all Histologies?
    Parker, Jessica E.
    Mauer, Caitlin
    Zheng, Wenxin
    Miller, David S.
    Lea, Jayanthi S.
    CURRENT WOMENS HEALTH REVIEWS, 2022, 18 (02) : 38 - 44
  • [3] Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome
    Watkins, Jaclyn C.
    Yang, Eric J.
    Muto, Michael G.
    Feltmate, Colleen M.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    Syngal, Sapna
    Yurgelun, Matthew B.
    Chittenden, Anu
    Hornick, Jason L.
    Crum, Christopher P.
    Sholl, Lynette M.
    Howitt, Brooke E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2017, 36 (02) : 115 - 127
  • [4] Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome
    Dillon, Jessica L.
    Gonzalez, Jorge L.
    DeMars, Leslie
    Bloch, Katarzyna J.
    Tafe, Laura J.
    HUMAN PATHOLOGY, 2017, 70 : 121 - 128
  • [5] Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for lynch syndrome
    Batte, Brittany A. L.
    Bruegl, Amanda S.
    Daniels, Molly S.
    Ring, Kari L.
    Dempsey, Katherine M.
    Djordjevic, Bojana
    Luthra, Rajyalakshmi
    Fellman, Bryan M.
    Lu, Karen H.
    Broaddus, Russell R.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 319 - 325
  • [6] Endometrial cancer in Lynch syndrome
    Zhao, Shuangshuang
    Chen, Lingli
    Zang, Yuqin
    Liu, Wenlu
    Liu, Shiqi
    Teng, Fei
    Xue, Fengxia
    Wang, Yingmei
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (01) : 7 - 17
  • [7] Lynch Syndrome and Endometrial Cancer
    Singh, Sareena
    Resnick, Kimberly E.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (04) : 265 - 269
  • [8] Lynch syndrome in patients treated for endometrial cancer
    Cetinkaya, K.
    Yuce, E.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (04) : 607 - 613
  • [9] Current and emerging trends in Lynch syndrome identification in women with endometrial cancer
    Resnick, Kimberly E.
    Hampel, Heather
    Fishel, Richard
    Cohn, David E.
    GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 128 - 134
  • [10] Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study
    Tsuruta, Tomohiko
    Todo, Yukiharu
    Yamada, Ryutaro
    Kuwahara, Ken
    Kurosu, Hiroyuki
    Minowa, Kaoru
    Minoura, Yuko
    Minobe, Shinichiro
    Suzuki, Hiroaki
    Kato, Hidenori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (07) : 744 - 750